Pharma Foods International Co Ltd
TSE:2929

Watchlist Manager
Pharma Foods International Co Ltd Logo
Pharma Foods International Co Ltd
TSE:2929
Watchlist
Price: 951 JPY -1.86% Market Closed
Market Cap: 26.7B JPY
Have any thoughts about
Pharma Foods International Co Ltd?
Write Note
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Income Statement

62.1B
-2%
Revenue
Growth Rates:
1 Year
-9%
3 Years
+33%
5 Years
+490%
7 Years
+1 216%
10 Years
+3 749%
5.1B
-2%
Operating Income
Growth Rates:
1 Year
+42%
3 Years
-10%
5 Years
+787%
7 Years
+5 617%
10 Years
-
3.2B
-17%
Net Income
Growth Rates:
1 Year
+4%
3 Years
-17%
5 Years
+541%
7 Years
+3 064%
10 Years
+35 911%

Earnings Waterfall
Pharma Foods International Co Ltd

Revenue
62.1B JPY
Cost of Revenue
-13.4B JPY
Gross Profit
48.8B JPY
Operating Expenses
-43.6B JPY
Operating Income
5.1B JPY
Other Expenses
-1.9B JPY
Net Income
3.2B JPY

Income Statement
Pharma Foods International Co Ltd

Rotate your device to view
Income Statement
Currency: JPY
Jul-2014 Oct-2014 Jan-2015 Apr-2015 Jul-2015 Oct-2015 Jan-2016 Apr-2016 Jul-2016 Oct-2016 Jan-2017 Apr-2017 Jul-2017 Oct-2017 Jan-2018 Apr-2018 Jul-2018 Oct-2018 Jan-2019 Apr-2019 Jul-2019 Oct-2019 Jan-2020 Apr-2020 Jul-2020 Oct-2020 Jan-2021 Apr-2021 Jul-2021 Oct-2021 Jan-2022 Apr-2022 Jul-2022 Oct-2022 Jan-2023 Apr-2023 Jul-2023 Oct-2023 Jan-2024 Apr-2024 Jul-2024
Revenue
Revenue
1 615
N/A
1 593
-1%
1 734
+9%
1 991
+15%
2 166
+9%
2 490
+15%
3 027
+22%
3 343
+10%
3 461
+4%
3 699
+7%
3 786
+2%
4 336
+15%
4 723
+9%
5 457
+16%
6 388
+17%
7 239
+13%
7 943
+10%
8 905
+12%
9 458
+6%
9 893
+5%
10 533
+6%
11 048
+5%
11 797
+7%
13 777
+17%
15 353
+11%
20 650
+34%
29 294
+42%
37 989
+30%
46 752
+23%
50 971
+9%
55 180
+8%
57 054
+3%
60 185
+5%
64 609
+7%
66 507
+3%
68 668
+3%
68 572
0%
67 684
-1%
65 081
-4%
63 210
-3%
62 147
-2%
Gross Profit
Cost of Revenue
(712)
(701)
(721)
(796)
(787)
(854)
(990)
(1 013)
(1 002)
(1 005)
(914)
(970)
(1 006)
(1 115)
(1 302)
(1 460)
(1 592)
(1 742)
(1 803)
(1 844)
(1 996)
(2 228)
(2 391)
(2 884)
(3 178)
(3 818)
(4 948)
(5 946)
(7 027)
(7 604)
(9 711)
(10 793)
(12 077)
(13 363)
(13 047)
(13 476)
(13 293)
(13 513)
(13 088)
(12 935)
(13 395)
Gross Profit
902
N/A
891
-1%
1 012
+14%
1 195
+18%
1 378
+15%
1 636
+19%
2 037
+25%
2 331
+14%
2 459
+6%
2 693
+10%
2 872
+7%
3 366
+17%
3 716
+10%
4 343
+17%
5 085
+17%
5 779
+14%
6 351
+10%
7 163
+13%
7 654
+7%
8 049
+5%
8 537
+6%
8 819
+3%
9 406
+7%
10 893
+16%
12 175
+12%
16 832
+38%
24 346
+45%
32 043
+32%
39 725
+24%
43 367
+9%
45 469
+5%
46 261
+2%
48 108
+4%
51 246
+7%
53 460
+4%
55 192
+3%
55 279
+0%
54 171
-2%
51 993
-4%
50 275
-3%
48 752
-3%
Operating Income
Operating Expenses
(931)
(1 107)
(1 263)
(1 449)
(1 750)
(2 195)
(2 612)
(2 670)
(2 505)
(2 804)
(2 974)
(3 271)
(3 627)
(4 297)
(5 361)
(5 735)
(6 055)
(6 844)
(6 784)
(7 634)
(7 960)
(8 637)
(10 127)
(10 453)
(11 435)
(16 736)
(22 102)
(28 413)
(34 052)
(34 690)
(37 682)
(42 290)
(47 028)
(53 935)
(55 295)
(53 409)
(51 669)
(47 758)
(45 957)
(45 033)
(43 639)
Selling, General & Administrative
(719)
(891)
(1 049)
(1 215)
(1 494)
(1 930)
(2 306)
(2 348)
(2 192)
(2 484)
(2 690)
(3 008)
(3 365)
(4 034)
(5 082)
(5 433)
(5 743)
(6 449)
(6 449)
(7 295)
(7 606)
(8 277)
(9 689)
(9 997)
(10 960)
(16 239)
(21 642)
(27 908)
(33 486)
(34 077)
(37 016)
(41 601)
(46 211)
(53 051)
(54 361)
(52 449)
(50 757)
(46 776)
(44 956)
(43 987)
(42 561)
Research & Development
(200)
(206)
(203)
(222)
(244)
(252)
(296)
(315)
(313)
(320)
(283)
(252)
(242)
(235)
(240)
(265)
(274)
(288)
(298)
(302)
(317)
(323)
(401)
(419)
(438)
(458)
0
(350)
(522)
(456)
(621)
(643)
(766)
(827)
(869)
(890)
(840)
(911)
(909)
(946)
(978)
Depreciation & Amortization
(12)
(11)
(11)
(12)
(12)
(13)
(11)
(7)
0
(1)
(1)
(12)
(20)
(29)
(38)
(36)
(38)
(38)
(38)
(38)
(37)
(37)
(37)
(37)
(37)
(39)
(40)
(42)
(43)
(42)
(42)
(44)
(51)
(58)
(66)
(71)
(72)
(78)
(99)
(99)
(99)
Other Operating Expenses
0
0
0
0
0
0
0
0
0
0
0
0
(0)
0
0
0
(0)
(70)
0
(0)
0
0
0
0
(0)
0
(420)
(113)
(1)
(115)
(2)
0
0
1
0
1
0
7
7
(1)
(1)
Operating Income
(28)
N/A
(216)
-669%
(250)
-16%
(254)
-1%
(372)
-47%
(560)
-50%
(575)
-3%
(340)
+41%
(46)
+86%
(111)
-139%
(102)
+8%
95
N/A
89
-6%
45
-49%
(275)
N/A
45
N/A
296
+563%
319
+7%
870
+173%
415
-52%
576
+39%
183
-68%
(721)
N/A
439
N/A
740
+68%
96
-87%
2 244
+2 231%
3 630
+62%
5 673
+56%
8 677
+53%
7 787
-10%
3 971
-49%
1 080
-73%
(2 689)
N/A
(1 835)
+32%
1 783
N/A
3 610
+102%
6 413
+78%
6 036
-6%
5 242
-13%
5 113
-2%
Pre-Tax Income
Interest Income Expense
30
35
40
173
265
266
228
100
(4)
(3)
11
(3)
34
31
36
64
42
38
36
10
3
4
(18)
(19)
(9)
(5)
14
36
26
20
27
22
54
11
(34)
(91)
(109)
(111)
(66)
(56)
(63)
Non-Reccuring Items
(0)
0
(59)
(62)
(115)
(113)
(54)
(52)
2
2
2
2
(30)
(24)
(24)
(24)
(66)
0
(70)
(70)
(1)
(1)
60
60
60
60
(2)
(1)
(1)
81
82
82
82
0
0
8
(42)
0
0
0
(225)
Gain/Loss on Disposition of Assets
0
0
0
0
0
0
0
0
0
0
0
(16)
(16)
0
0
0
0
0
0
0
32
0
0
0
0
0
0
0
0
0
0
0
77
0
0
71
(6)
0
0
0
0
Total Other Income
10
13
3
33
37
45
70
68
77
57
50
57
46
43
37
34
41
46
89
94
58
78
47
59
58
60
61
64
67
92
106
132
130
222
194
78
89
25
26
6
209
Pre-Tax Income
12
N/A
(168)
N/A
(266)
-59%
(109)
+59%
(184)
-70%
(361)
-96%
(331)
+8%
(223)
+33%
29
N/A
(55)
N/A
(39)
+28%
136
N/A
124
-9%
95
-23%
(227)
N/A
119
N/A
314
+164%
402
+28%
925
+130%
448
-52%
669
+49%
263
-61%
(632)
N/A
539
N/A
849
+57%
211
-75%
2 316
+997%
3 730
+61%
5 765
+55%
8 870
+54%
8 001
-10%
4 208
-47%
1 423
-66%
(2 456)
N/A
(1 675)
+32%
1 849
N/A
3 542
+92%
6 327
+79%
5 996
-5%
5 192
-13%
5 034
-3%
Net Income
Tax Provision
(3)
(3)
(3)
(3)
(3)
(4)
(3)
(4)
(2)
(3)
(5)
(13)
(19)
(23)
(26)
(23)
9
1
(1)
(2)
(161)
(161)
(158)
(161)
(158)
(165)
(536)
(1 291)
(1 924)
(2 370)
(2 152)
(2 205)
(1 797)
(971)
(1 175)
(871)
(462)
(1 139)
(1 233)
(1 323)
(1 828)
Income from Continuing Operations
9
(171)
(269)
(112)
(188)
(365)
(334)
(227)
26
(58)
(45)
123
105
73
(253)
96
323
403
925
446
508
102
(790)
378
691
47
1 780
2 439
3 841
6 500
5 849
2 003
(374)
(3 427)
(2 850)
978
3 080
5 188
4 763
3 869
3 206
Income to Minority Interest
0
0
0
0
0
2
2
(1)
(0)
(3)
(4)
(3)
(4)
(6)
(7)
(8)
(9)
(12)
(10)
(8)
(8)
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
0
0
0
0
0
Net Income (Common)
9
N/A
(171)
N/A
(269)
-58%
(112)
+58%
(188)
-68%
(363)
-93%
(332)
+8%
(228)
+31%
26
N/A
(61)
N/A
(49)
+20%
120
N/A
101
-16%
67
-34%
(260)
N/A
88
N/A
314
+255%
391
+25%
912
+133%
436
-52%
500
+15%
99
-80%
(790)
N/A
378
N/A
691
+83%
47
-93%
1 780
+3 728%
2 439
+37%
3 841
+57%
6 499
+69%
5 849
-10%
2 003
-66%
(374)
N/A
(3 425)
-816%
(2 849)
+17%
978
N/A
3 081
+215%
5 187
+68%
4 763
-8%
3 869
-19%
3 205
-17%
EPS (Diluted)
0.3
N/A
-5.89
N/A
-9.28
-58%
-3.86
+58%
-6.49
-68%
-12.5
-93%
-11.45
+8%
-7.85
+31%
0.89
N/A
-2.08
N/A
-1.68
+19%
4.14
N/A
3.49
-16%
2.3
-34%
-8.94
N/A
3.04
N/A
10.8
+255%
13.47
+25%
31.41
+133%
14.99
-52%
17.21
+15%
3.42
-80%
-27.21
N/A
13.02
N/A
23.78
+83%
1.6
-93%
61.28
+3 730%
83.77
+37%
132.14
+58%
223.96
+69%
201.77
-10%
68.96
-66%
-12.89
N/A
-118.1
-816%
-98.86
+16%
33.9
N/A
106.7
+215%
179.82
+69%
165.57
-8%
137.77
-17%
112.69
-18%

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Follow us
Join more than 201,200+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.